Cargando…
Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors
Succinate dehydrogenase (SDH) and fumarate hydratase (FH) are tricarboxylic acid (TCA) cycle enzymes and tumor suppressors. Loss-of-function mutations give rise to hereditary paragangliomas/pheochromocytomas and hereditary leiomyomatosis and renal cell carcinoma. Inactivation of SDH and FH results i...
Autores principales: | Hoekstra, Attje S., de Graaff, Marieke A., Briaire-de Bruijn, Inge H., Ras, Cor, Seifar, Reza Maleki, van Minderhout, Ivonne, Cornelisse, Cees J., Hogendoorn, Pancras C.W., Breuning, Martijn H., Suijker, Johnny, Korpershoek, Esther, Kunst, Henricus P.M., Frizzell, Norma, Devilee, Peter, Bayley, Jean-Pierre, Bovée, Judith V.M.G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770736/ https://www.ncbi.nlm.nih.gov/pubmed/26472283 |
Ejemplares similares
-
Non‐ossifying fibroma: A RAS‐MAPK driven benign bone neoplasm
por: Bovée, Judith VMG, et al.
Publicado: (2019) -
Kinome profiling of myxoid liposarcoma reveals NF-kappaB-pathway kinase activity and Casein Kinase II inhibition as a potential treatment option
por: Willems, Stefan M, et al.
Publicado: (2010) -
Global DNA 5hmC and CK19(5hmC+) Contents: A Promising Biomarker for Predicting Prognosis in Small Hepatocellular Carcinoma
por: Jiang, Jinhua, et al.
Publicado: (2021) -
Exploring role of 5hmC as potential marker of chemoresistance
por: Kharat, Suhas S., et al.
Publicado: (2020) -
Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell Carcinomas
por: Yoo, Angela, et al.
Publicado: (2022)